Friday, January 26, 2018

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

Researchers have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What’s more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells.



from Top Health News – ScienceDaily http://bit.ly/2neV6BB
from Tumblr http://bit.ly/2ndDoys

No comments:

Post a Comment